Skip to content

The library now covers 173 peptides. Browse it

Growth hormone · blend vial · GHRH analog for GH/IGF-1 research

CJC-1295 / Ipamorelin Blend

Modified GRF 1-29, Mod GRF 1-29, CJC-1295 no DAC, CJC-1295 DAC

A GHRH analog sold with or without DAC. Both forms exist: DAC albumin-binding stretches half-life to days; no-DAC (Mod GRF 1-29) stays a pulse. NovaEvum’s vial is the no-DAC + Ipamorelin blend. Literature score 40/100. FDA has flagged cardiac-event risk in this class.

Library entry →

  • GH release
  • Recovery
  • Sleep
Catalog fill
5 mg + 5 mg
Typical water
2 mL
Route
Subcutaneous
Cycle
8–12 weeks.
Approval
Not FDA-approved. No recent trials that led to a licence.
Status
Research chemical. WADA prohibited. 2024 compounding review is not approval.
Evidence
Early-phase work before 2020. Nothing that became a product.
Research score
40 / 100

Mechanism

GHRH-receptor drive of pituitary GH. DAC (maleimidopropionic acid) binds albumin (~6–8 day half-life). The catalog blend is the short analog plus Ipamorelin, not weekly DAC.

Safety file

Long-term human safety unknown. FDA notes cardiac-event risk. GH/IGF-1 elevation can mean water retention and insulin resistance.

  • Injection-site reactions
  • Numbness
  • Water retention
  • Headache
  • Joint stiffness
  • Insulin resistance

Reconstitution

2 mL bacteriostatic water yields 2.5 mg/mL of each peptide. A 100 mcg-of-each pulse is 4 units; 200 mcg of each is 8 units.

Research amounts

1–2 pulses daily, often evening. No-DAC CJC is short-acting, so it is pulsed, not weekly.

StepAmountFrequencyNotes
Standard pulse100 mcg each1–2× daily4 units from a 2 mL reconstitution
Higher pulse200 mcg each1–2× daily8 units

Storage

Lyophilized
−20 °C freezer preferred; a refrigerator is also acceptable. Do not open a cold vial — wait 15–30 minutes so it does not sweat. Avoid freeze–thaw cycling.
After water
2–8 °C, dark, up to 45 days when mixed with bacteriostatic water. Mixed vials stay in their box. Sterile water (no preservative) is single-use.

Worksheet notes

  • You cannot change the CJC:Ipamorelin ratio from this vial.
  • Do not also run a separate Ipamorelin vial on the same days unless you intend to raise only the secretagogue.
  • Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
  • Amounts on this sheet are reconstitution math for the vial, not a recommendation.

Full protocol

Titration, schedule, and handling

The complete protocol for CJC-1295 / Ipamorelin Blend. Where it differs from the worksheet amounts above, the worksheet reflects the NovaEvum vial.

Reconstitution

Concentration by vial size and water volume
Vial2 mL water3 mL water
10 mg5 mg/mL3.33 mg/mL

The classic GH pairing of CJC-1295 (No DAC) and Ipamorelin in a 1:1 ratio. The 10 mg vial holds 5 mg of each. Doses below are stated per peptide (they always move together); the calculator works in total blend mg, so 0.2 mg of each peptide is 0.4 mg of total blend.

  1. Use bacteriostatic water as the diluent.
  2. Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
  3. Swirl gently to mix, then leave it to dissolve. Do not shake.
  4. Give it a few minutes. The finished solution should be clear and colourless.

Protocol

Route: Subcutaneous

Why these two together

  • CJC-1295 (No DAC) tells the pituitary to make growth hormone, while Ipamorelin tells it to release it: two different signals on the same gland
  • The No DAC version is used because its short half-life lines up with Ipamorelin, which keeps the natural pulsing pattern intact
  • They are combined in one syringe and one shot

Standard protocol (subcutaneous)

  • 0.1 mg of each peptide before bed is the standard starting dose, moving to 0.2 mg of each for most people
  • On the 10 mg vial (5 mg of each) at a 2 mL fill, 0.1 mg of each is a 0.04 mL draw (4 units) and 0.2 mg of each is 0.08 mL (8 units)
  • Dose once daily, 5 days on, 2 days off

Timing matters

  • Inject before bed, at least 2 hours after your last meal
  • Food (especially carbs and fat) blunts the GH pulse, and the body releases its own GH overnight, so a fasted bedtime shot lines up with natural timing
  • A fasted morning or post-workout dose is the other common slot

Titration and ceiling

  • Start at 0.1 mg of each and increase by about 0.05 mg every 1 to 2 weeks if you want, up to a common ceiling of 0.3 mg of each per day (0.12 mL / 12 units at the 2 mL fill)
  • 0.1 mg is already a saturating dose for many, so more is not always better

Dosing detail

  • 0.1 mg of each peptide is the standard start, 0.2 mg of each suits most people, 0.3 mg of each is a common ceiling.
  • At the 2 mL fill: 0.1 mg of each is 0.04 mL (4 units), 0.2 mg is 0.08 mL (8 units), 0.3 mg is 0.12 mL (12 units).
  • Inject once daily before bed, fasted (2 hours after eating), 5 days on and 2 off.
  • Both peptides are short-acting and share one syringe, so the pairing keeps the natural pulsatile GH release.

Duration

  • Run 8 to 12 weeks (extend to 16 if desired), 5 on / 2 off, then a break.

Notes

  • The most common GH peptide pairing.
  • One daily shot covers both peptides instead of running two separate vials.
  • A brief flush after injecting is common and harmless. Inject subcutaneously and rotate sites.

Storage and handling

  • Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
  • Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 90 days.
  • Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
  • If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.